AMY BICKAR: Open Payments
NPI 1285864967 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 9 payments from 9 companies in 2025. Trend: 2023 $1,417 · 2024 $1,321 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $130 |
| Geron Corporation | 1 | $112 |
| GlaxoSmithKline, LLC. | 1 | $112 |
| PharmaEssentia USA Corporation | 1 | $111 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $91 |
| AstraZeneca Pharmaceuticals LP | 1 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $40 |
| Genmab U.S., Inc. | 1 | $39 |
| Genentech USA, Inc. | 1 | $18 |
Products named: OPDIVO, RYTELO, OJJAARA, BESREMI, FIRDAPSE, DATROWAY, Tecentriq.
Industry payments across FL — which companies pay providers there.
